Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • US Federal AI Adoption: 1 Great Deal, $3.1 Billion in Savings Technology
  • Life-Saving German Technology on Indian Highways: How One TTMA Prevented a Multi-Casualty Disaster on NH-53 Business
  • Indian Startup LoveForLife Rehabilitation Services Honoured with Zero Project ’24 Lifestyle
  • JUST CORSECA Unveils Stylish and Powerful SSPEED and STORM Charger Range for Modern Consumers Business
  • Nallapati Rajeshwari President of Delhi World Schools Receives hmtv Naari Puraskar from Telangana Education Minister Sabitha Indra Reddy Business
  • BNI Greater Surat’s Business Conclave To Attract Over 10,000 Participants Business
  • Cyble Appoints Former Cognition IP Executive Uday Pulleti as Senior Director – AI Business
  • Inspired by the Hon’ble Prime Minister’s Vision, a new Hindi learning Initiative is Born National

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Cool Caps Industries Announces Rs 279.97 Crore Rights Issue to Fuel Growth and Main Board Migration Business
  • Sayba Group’s Strategic Redevelopment Projects to Transform Jogeshwari and Bandra West Business
  • Dharni Capital Services Limited brings its IPO for Rs 1074 lakhs; Issue opens on the 18th of January, 2023 Business
  • Empowering the Future – Coapps : Worlds Largest AI/ML Product Development & Outsourcing Company Business
  • Grand Opening of ZOILA Restobar at Fun Republic (Cinepolis) in the presence of celebs Business
  • Experience that shaped Master Aryen Suresh Kute’s Entrepreneurial Journey Business

Recent Posts

  • Standard Engineering Technology Limited Delivers Strong Q3 and 9M FY26 Performance
  • Hourly Stays Gain Ground as Platforms Like Brevistay Address Safety and Trust Concerns
  • Avani Institute of Design Successfully Hosts Avani Winter Workshop 2026, a Multi-Disciplinary Platform for Experimental Learning
  • Surat to host organic Mud Fest on Dhuleti, attract participants from India and abroad
  • Travels and Rentals Ltd Announces Rs 16.80 Crore Rights Issue; Record Date Set for Jan 28

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Zoya by Tata Unveils Exquisite Jewelry Collections at Palladium Ahmedabad, Elevating the Essence of Femininity and Elegance Business
  • Cedaar Textile Limited Announces IPO Opening June 30, 2025 Business
  • Champion: When A Sports Film Tries To Win With Heart Before It Wins The Scoreboard Entertainment
  • Discover Your World: Future Choice Hospitality Unveils Travel Magic Lifestyle
  • Kingston Celebrates Its 35th Year Anniversary with its New Micro-film Business
  • AVEE Kids Introduces an Exciting New Range of Natural Products for Children Aged 5 to 12 Health
  • By the Surat Obstetric and Gynecological Society Health
  • Garrett Motion Launches Advanced Research Hub at IISc for Next-Gen Mobility Solutions Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme